US2018312530A1PendingUtilityA1

Processes for making alkylated arylpiperazine and alkylated arylpiperidine compounds including novel intermediates

Assignee: JOHNSON MATTHEY PLCPriority: Jun 16, 2014Filed: Apr 20, 2018Published: Nov 1, 2018
Est. expiryJun 16, 2034(~7.9 yrs left)· nominal 20-yr term from priority
C07C 39/00C07D 261/20C07D 209/56C07D 239/88C07D 413/12C07D 417/08C07D 519/00C07D 471/12C07D 215/22C07D 311/20C07D 417/12C07D 401/12C07D 487/12C07D 275/06C07D 403/12C07D 413/04C07D 311/06C07D 413/14C07D 209/52C07D 215/227C07D 241/04
65
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

wherein, R1 and R2 are individually selected from hydrogen, alkyl, substituted or alkyl; n=0, 1, or 2; Y=NR3R4, OR5, or SR5, where R3 and R4 are individually selected from acyl or sulfonyl, and where R5 is aryl or heteroaryl, or heterocyclic; and Ar is an aryl, heteroaryl, or heterocyclic compound.

Claims

exact text as granted — not AI-modified
1 - 14 . (canceled) 
     
     
         15 . A method of preparing a 6-fluoro-3-[1-(3-substituted propyl)piperidin-4-yl]-1,2-benzoxazole of the following formula 
       
         
           
           
               
               
           
         
       
       comprising
 (i) alkylating 1,3,2-dioxathiane 2,2-dioxide having the formula 
 
       
         
           
           
               
               
           
         
       
       with a phenolic compound of the formula 
       
         
           
           
               
               
           
         
       
       in the presence of base selected from potassium carbonate, sodium carbonate, magnesium carbonate, calcium carbonate, potassium hydroxide, sodium hydroxide, magnesium hydroxide or calcium hydroxide, to form the corresponding alkylation compound of the formula 
       
         
           
           
               
               
           
         
       
       wherein Q is potassium, sodium, magnesium or calcium;
 (ii) hydrolyzing the alkylation compound of step (i) with aqueous acid to obtain the corresponding hydroxyl compound of formula 
 
       
         
           
           
               
               
           
         
         (iii) converting the compound of formula 
       
       
         
           
           
               
               
           
         
       
       of step (ii) to the corresponding alkylating agent compound of formula 
       
         
           
           
               
               
           
         
       
       wherein LG is selected from the group consisting of aryl sulfonate or alkyl sulfonate; and
 (iv) alkylating the compound of formula 
 
       
         
           
           
               
               
           
         
       
       of step (iii) with the compound of formula 
       
         
           
           
               
               
           
         
       
       in the presence of a base selected from potassium carbonate, sodium carbonate, magnesium carbonate, calcium carbonate, potassium hydroxide, sodium hydroxide, magnesium hydroxide or calcium hydroxide. 
     
     
         16 . The process of claim  1  wherein the base of steps (i) and (iv) is potassium carbonate. 
     
     
         17 . The process of claim  1  wherein LG is methylsulfonate. 
     
     
         18 . The process of claim  1  wherein Y is 
       
         
           
           
               
               
           
         
       
     
     
         19 . The process of claim  1  wherein Y is

Join the waitlist — get patent alerts

Track US2018312530A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.